Tag: Cancer: Ovarian
Ovarian CA Encompasses More Than One Kind of Malignancy
Better understanding needed to improve prevention, detection, treatment, U.S. panel notes
Weekly Paclitaxel Doesn’t Up Survival in Ovarian Cancer
Among patients not receiving bevacizumab, weekly paclitaxel tied to improved progression-free survival
Inherited Mutations in 18 Percent With Ovarian Cancer
Mutations seen in BRCA1/2, DNA mismatch repair genes, other suspected/established risk genes
Surgery, Chemo Best for Elderly With Advanced Ovarian Cancer
Longest survival time for primary debulking surgery, chemotherapy with optimal timeframe
Longer Follow-Up Needed to Evaluate Ovarian CA Screening
Significant reduction in mortality with multimodal screening when prevalent cases excluded
Pre-Op Blood Tests May Predict Post-Op Morbidity in Ovarian CA
Pre-op thrombocytosis, leukocytosis tied to post-op morbidity; increased mortality for patients with both
Vitiligo Can Mask Symptoms of Acanthosis Nigricans
In this case report, masking could have resulted in delay of identification of ovarian cancer
Adjuvant Hormone Tx Ups Survival in Epithelial Ovarian CA
Significant improvement in overall, relapse-free survival for women receiving five-years of AHT
Eudaimonic Well-Being Tied to Ovarian Tumor Neuroeffector
Positive affect, psychological distress not associated with tumor norepinephrine
Nonselective Beta-Blocker Use Ups Survival in Ovarian Cancers
Longer median overall survival for patients receiving any beta-blocker versus nonusers
